Show
Sort by
-
- Journal Article
- A1
- open access
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease
(2024) RHEUMATOLOGY. -
- Journal Article
- A1
- open access
Does the impact of COVID‐19 on patients with systemic sclerosis change over time?
-
- Journal Article
- A1
- open access
Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression
-
- Journal Article
- A1
- open access
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort
-
Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease : a EUSTAR database analysis
-
Sex influence on outcomes of patients with systemic sclerosis–associated interstitial lung disease : a EUSTAR database analysis
-
Late skin fibrosis in systemic sclerosis : a study from the EUSTAR cohort
-
Glucocorticoids prescribing practices in systemic sclerosis : an analysis of the EUSTAR database
-
Cohort enrichment strategies for progressive interstitial lung disease in systemic sclerosis From European Scleroderma Trials and Research
-
Use of platelet inhibitors for digital ulcers related to systemic sclerosis : EUSTAR study on derivation and validation of the DU-VASC model